WO1997012850A3 - Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ xsny für radioaktive isotope - Google Patents

Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ xsny für radioaktive isotope Download PDF

Info

Publication number
WO1997012850A3
WO1997012850A3 PCT/DE1996/001826 DE9601826W WO9712850A3 WO 1997012850 A3 WO1997012850 A3 WO 1997012850A3 DE 9601826 W DE9601826 W DE 9601826W WO 9712850 A3 WO9712850 A3 WO 9712850A3
Authority
WO
WIPO (PCT)
Prior art keywords
xsny
sulphide
bifunctional
type
chelating agents
Prior art date
Application number
PCT/DE1996/001826
Other languages
English (en)
French (fr)
Other versions
WO1997012850A2 (de
Inventor
Ludger Dinkelborg
Christoph Stephan Hilger
Wolfgang Kramp
Johannes Platzek
Bernd Raduechel
Sebastian Erber
Original Assignee
Diagnostikforschung Inst
Ludger Dinkelborg
Christoph Stephan Hilger
Wolfgang Kramp
Johannes Platzek
Bernd Raduechel
Sebastian Erber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostikforschung Inst, Ludger Dinkelborg, Christoph Stephan Hilger, Wolfgang Kramp, Johannes Platzek, Bernd Raduechel, Sebastian Erber filed Critical Diagnostikforschung Inst
Priority to EP96945341A priority Critical patent/EP0851847A2/de
Priority to AU15399/97A priority patent/AU1539997A/en
Publication of WO1997012850A2 publication Critical patent/WO1997012850A2/de
Publication of WO1997012850A3 publication Critical patent/WO1997012850A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Die Erfindung betrifft neue Verbindungen der allgemeinen Formel (I): M - L, worin M für ein Radioisotop von Tc oder Re und L für einen Liganden der allgemeinen Formel (II): B-CR?1R2-(CR3R4)¿n=1,2-S-CHR?5-CHR6-SO¿2-NH-CR?7R8-(CR9R10)¿m=1,2-D steht, worin R?1, R2, R3, R4, R5, R6, R7, R8, R9 und R10¿ unterschiedliche Bedeutung haben können und B und D für eine weitere Gruppe stehen, die einerseits für die koordinative Bindung von Metallionen, andererseits für die Kopplung an sich selektiv anreichernde Verbindungen geeignet sind. Die Kopplung an sich selektiv anreichernde Verbindungen kann alternativ auch über R8 erfolgen. Die neuen Verbindungen dienen zur Komplexierung von Technetium und Rhenium und werden in der medizinischen Diagnostik und Therapie eingesetzt.
PCT/DE1996/001826 1995-09-21 1996-09-19 Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ xsny für radioaktive isotope WO1997012850A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP96945341A EP0851847A2 (de) 1995-09-21 1996-09-19 Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ xsny für radioaktive isotope
AU15399/97A AU1539997A (en) 1995-09-21 1996-09-19 Bifunctional, sulphide-containing sulphonamide-chelating agents of xsny type for radioactive isotopes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19536780.4 1995-09-21
DE1995136780 DE19536780A1 (de) 1995-09-21 1995-09-21 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNY für radioaktive Isotope

Publications (2)

Publication Number Publication Date
WO1997012850A2 WO1997012850A2 (de) 1997-04-10
WO1997012850A3 true WO1997012850A3 (de) 1997-07-10

Family

ID=7773887

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1996/001826 WO1997012850A2 (de) 1995-09-21 1996-09-19 Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ xsny für radioaktive isotope

Country Status (5)

Country Link
EP (1) EP0851847A2 (de)
AU (1) AU1539997A (de)
CA (1) CA2232620A1 (de)
DE (1) DE19536780A1 (de)
WO (1) WO1997012850A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652374A1 (de) * 1996-12-04 1998-06-10 Schering Ag Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188256A2 (de) * 1985-01-14 1986-07-23 NeoRx Metall-Radionuklid markiertes Protein für Diagnose und Therapie
EP0200492A1 (de) * 1985-04-26 1986-11-05 The President And Fellows Of Harvard College Radiodiagnostische Mittel
EP0247866A1 (de) * 1986-05-29 1987-12-02 Mallinckrodt, Inc. (a Delaware corporation) Kupplungsmittel zum Radiomarkieren von Proteinen
EP0618191A1 (de) * 1993-04-02 1994-10-05 AMERSHAM INTERNATIONAL plc Metall-chelatierende Verbindungen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188256A2 (de) * 1985-01-14 1986-07-23 NeoRx Metall-Radionuklid markiertes Protein für Diagnose und Therapie
EP0200492A1 (de) * 1985-04-26 1986-11-05 The President And Fellows Of Harvard College Radiodiagnostische Mittel
EP0247866A1 (de) * 1986-05-29 1987-12-02 Mallinckrodt, Inc. (a Delaware corporation) Kupplungsmittel zum Radiomarkieren von Proteinen
EP0618191A1 (de) * 1993-04-02 1994-10-05 AMERSHAM INTERNATIONAL plc Metall-chelatierende Verbindungen

Also Published As

Publication number Publication date
AU1539997A (en) 1997-04-28
CA2232620A1 (en) 1997-04-10
EP0851847A2 (de) 1998-07-08
WO1997012850A2 (de) 1997-04-10
DE19536780A1 (de) 1997-03-27

Similar Documents

Publication Publication Date Title
EP0417870A3 (en) Chelates for complexation of radioactive isotopes, their metal complexes and their use in diagnosis and therapy
LV11430A (lv) 2-Piridilmetilenpoliazamakrociklofosfonskabes to kompleksi un atvasinajumi izmantosanai par kontrastvielam
IL111083A0 (en) Tetraazacyclododecane macrocycle derivatives, pharmaceutical compositions and diagnostic compositions containing the same
AU4299496A (en) Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods ofpreparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions
IE842799L (en) Zinc containing composition
GB2157563B (en) Pharmaceutical compositions containing iron complexes
DE3674515D1 (en) Carboxy, carbalkoxy und carbamyl substituierte isonitril-radionukleid-komplexe.
WO1997010852A3 (de) Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ xsns für radioaktive isotope
WO1997010853A3 (de) Bifunktionelle nicotinamid-chelatbildner vom typ n2s2 für radioaktive isotope
IL55338A (en) Analgesic pharmaceutical compositions containing 2,3-dialkylpyrido(1,2-a)pyrimidine-4-one derivatives,some new such compounds and their preparation
WO1992007860A3 (en) Technetium-99m complexes for use as radiopharmaceuticals
AU6501794A (en) Chelating agents of the type xn1s1o1 for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy
HUT73529A (en) New bis-naphthalimides for the treatment of cancer
WO1997012636A3 (de) Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ s2ny für radioaktive isotope
ES8103969A1 (es) Un procedimiento para la preparacion de una solucion inyec- table estable de un quelato de oxitetraciclina
ZA961395B (en) Metal complexes suitable for use in diagnosis and therapy
WO1997012850A3 (de) Bifunktionelle sulfidhaltige sulfonamid-chelatbildner vom typ xsny für radioaktive isotope
ES468170A1 (es) Un procedimiento para la preparacion de un nuevo derivado demorfina
IL110462A0 (en) Tris(isonitrile)copper(I) sulfate complexes and their preparation
ES8504166A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz(b,e) oxepina.
IL70082A0 (en) 1-aroyl-5-oxo-2-pyrrolidinepropanoic acids and salts and esters thereof,their preparation and pharmaceutical compositions containing them
DE69117741D1 (de) Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen
HU9802311D0 (en) Chelating agents for complex formation with radioactive isotopes, their metal complexes and the use thereof for diagnostic and therapeutic purposes
JO1658B1 (en) New vehicles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA HU JP KR NO NZ US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA HU JP KR NO NZ US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996945341

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2232620

Country of ref document: CA

Ref country code: CA

Ref document number: 2232620

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996945341

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996945341

Country of ref document: EP